Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Apr 18;11(4):872.
doi: 10.3390/nu11040872.

Oxidative Stress and Non-Alcoholic Fatty Liver Disease: Effects of Omega-3 Fatty Acid Supplementation

Affiliations

Oxidative Stress and Non-Alcoholic Fatty Liver Disease: Effects of Omega-3 Fatty Acid Supplementation

Jinchunzi Yang et al. Nutrients. .

Abstract

Aging is a complex phenomenon characterized by the progressive loss of tissue and organ function. The oxidative-stress theory of aging postulates that age-associated functional losses are due to the accumulation of ROS-induced damage. Liver function impairment and non-alcoholic fatty liver disease (NAFLD) are common among the elderly. NAFLD can progress to non-alcoholic steatohepatitis (NASH) and evolve to hepatic cirrhosis or hepatic carcinoma. Oxidative stress, lipotoxicity, and inflammation play a key role in the progression of NAFLD. A growing body of evidence supports the therapeutic potential of omega-3 polyunsaturated fatty acids (n-3 PUFA), mainly docosahaexenoic (DHA) and eicosapentaenoic acid (EPA), on metabolic diseases based on their antioxidant and anti-inflammatory properties. Here, we performed a systematic review of clinical trials analyzing the efficacy of n-3 PUFA on both systemic oxidative stress and on NAFLD/NASH features in adults. As a matter of fact, it remains controversial whether n-3 PUFA are effective to counteract oxidative stress. On the other hand, data suggest that n-3 PUFA supplementation may be effective in the early stages of NAFLD, but not in patients with more severe NAFLD or NASH. Future perspectives and relevant aspects that should be considered when planning new randomized controlled trials are also discussed.

Keywords: aging; non-alcoholic fatty liver disease; omega-3 fatty acids; oxidative stress.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Multiple parallel hits NAFLD pathogenesis model. Non-alcoholic fatty liver disease (NAFLD). Non-alcoholic steatohepatitis (NASH). Endoplasmic reticulum (ER).
Figure 2
Figure 2
Flowchart of selection process based on n-3 PUFA and oxidative stress.
Figure 3
Figure 3
Flowchart of selection process based on n-3 PUFA and NAFLD/NASH.

Similar articles

Cited by

References

    1. Da Costa J.P., Vitorino R., Silva G.M., Vogel C., Duarte A.C., Rocha-Santos T. A synopsis on aging—Theories, mechanisms and future prospects. Ageing Res. Rev. 2016;29:90–112. doi: 10.1016/j.arr.2016.06.005. - DOI - PMC - PubMed
    1. Kirkwood T.B.L. Systems biology of ageing and longevity. Philos. Trans. R. Soc. B Biol. Sci. 2011;366:64–70. doi: 10.1098/rstb.2010.0275. - DOI - PMC - PubMed
    1. Picca A., Fanelli F., Calvani R., Mulè G., Pesce V., Sisto A., Pantanelli C., Bernabei R., Landi F., Marzetti E. Gut Dysbiosis and Muscle Aging: Searching for Novel Targets against Sarcopenia. Mediat. Inflamm. 2018;2018:7026198. doi: 10.1155/2018/7026198. - DOI - PMC - PubMed
    1. North B.J., Sinclair D.A. The intersection between aging and cardiovascular disease. Circ. Res. 2012;110:1097–1108. doi: 10.1161/CIRCRESAHA.111.246876. - DOI - PMC - PubMed
    1. Gunasekaran U., Gannon M. Type 2 Diabetes and the Aging Pancreatic Beta Cell. Aging. 2011;3:565–575. doi: 10.18632/aging.100350. - DOI - PMC - PubMed

Publication types

MeSH terms

Substances